Abbvie Inc
NYSE:ABBV
Revenue Breakdown
Breakdown by Geography
Abbvie Inc
Total Revenue:
54.3B
USD
|
United States:
41.9B
USD
|
Other Countries:
5B
USD
|
Germany:
1.3B
USD
|
Canada:
1.1B
USD
|
Japan:
1B
USD
|
China:
950m
USD
|
France:
780m
USD
|
Spain:
501m
USD
|
Italy:
484m
USD
|
Australia:
472m
USD
|
Brazil:
439m
USD
|
Breakdown by Segments
Abbvie Inc
Total Revenue:
54.3B
USD
|
H U M I R A:
14.4B
USD
|
Skyrizi:
7.8B
USD
|
Rinvoq:
4B
USD
|
Imbruvica:
3.6B
USD
|
Other Products:
3B
USD
|
Botox Therapeutic:
3B
USD
|
Vraylar:
2.8B
USD
|
Botox Cosmetic:
2.7B
USD
|
Venclexta:
2.3B
USD
|
Mavyret:
1.4B
USD
|
Juvederm Collection:
1.4B
USD
|
Other Aesthetics:
1.2B
USD
|
Linzess/Constella:
1.1B
USD
|
Ubrelvy:
815m
USD
|
Other Eye Care:
803m
USD
|
Ozurdex:
472m
USD
|
Duodopa:
468m
USD
|
Restasis:
436m
USD
|
Lumigan/Ganfort:
432m
USD
|
Qulipta:
408m
USD
|
Other Neuroscience:
276m
USD
|
Alphagan/Combigan:
272m
USD
|